Written by
Şevval T
Şevval T Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
...
Views
Read Time
...
views
Read Time
Nephroblastoma: Another Name for a Wilms Tumor
Nephroblastoma: Another Name for a Wilms Tumor 3

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that primarily affects children. This cancer is a big worry for parents and doctors because it’s the main kidney cancer in kids.

Getting a Wilms tumor or nephroblastoma diagnosis can feel scary. We’re here to help with top-notch healthcare for patients from around the world. We offer full support and the latest treatments.

Key Takeaways

  • Wilms tumor is also known as nephroblastoma, a type of kidney cancer.
  • It mainly affects kids and makes up about 90% of childhood kidney cancers.
  • Knowing about the condition is key for good treatment and support.
  • Advanced medical treatments and support services are available for international patients.
  • Early diagnosis and full care can greatly improve chances of recovery.

Understanding Wilms Tumor and Its Alternative Name

image 26978 LIV Hospital
Nephroblastoma: Another Name for a Wilms Tumor 4

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that primarily affects children. Knowing both names is key to understanding this condition.

The Medical Term: Nephroblastoma

Nephroblastoma is the medical term for Wilms tumor. It points to the kidney’s role in the tumor’s development. The term is used in medical and scientific fields to detail the tumor’s nature.

Using “nephroblastoma” in medical texts highlights the tumor’s specific traits. It’s a cancer that mainly affects children. It usually starts in one kidney but can happen in both.

TermUsage ContextFocus
Wilms TumorGeneral, ClinicalCondition’s overall impact
NephroblastomaMedical, ScientificTumor’s cellular origin and pathology

Why Two Different Names Exist

The two names for this condition come from its history and how it’s seen. “Wilms tumor” honors Max Wilms, the surgeon who first identified it. It covers the clinical and historical sides of the disease.

“Nephroblastoma” focuses on the tumor’s nature as a kidney cancer. This naming helps doctors and patients talk clearly about the condition and its treatment.

It’s important for patients and families to know both names. This ensures they can talk clearly about the condition and its treatment.

The History and Discovery of Nephroblastoma

Max Wilms, a German surgeon, first described Wilms tumor in the late 19th century. This cancer mainly affects children. Knowing its history helps us understand how we diagnose and treat it today.

Max Wilms and His Contribution

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that primarily affects children.

Wilms’ work was important because it highlighted the disease and opened doors for more research on its causes and treatments.

Wilms described the tumor’s key features and who it usually affects. His findings helped make nephroblastoma a known condition. Today, we know much more about Wilms tumor, thanks to advances in science and medicine.

Evolution of Understanding the Disease

After Max Wilms’ discovery, our understanding and treatment of nephroblastoma have grown a lot. Now, we see it as a complex disease with different types and outcomes. Thanks to new treatments, more kids with Wilms tumor are surviving.

We now know a lot about Wilms tumor’s genetics and biology, thanks to modern research. This knowledge helps us tailor treatments to each child, aiming for the best results with fewer side effects.

In summary, the history of Wilms tumor shows how far we’ve come in treating children’s cancer. From Max Wilms’ early work to today’s advanced treatments, we’ve made great strides. Ongoing research and teamwork are key to keeping improving care for kids with this disease.

Defining Characteristics of Nephroblastoma

Knowing the key traits of nephroblastoma is vital for diagnosis and treatment. This cancer, also known as Wilms tumor, starts in immature kidney cells. Its early cell stage greatly affects its growth and behavior.

Cellular Origin and Development

Nephroblastoma comes from the metanephric blastema, a group of cells meant to become kidney tissue. The tumor’s cells can vary, showing both early and mature forms. This mix is a key feature of the disease.

Genetic and environmental factors might cause nephroblastoma. It can have different cell types, showing its early kidney cell origin.

Common Locations and Spread Patterns

Nephroblastoma mainly hits the kidneys, with most cases starting in one kidney. Yet, 5-7% of cases affect both kidneys. The tumor can grow big before being found, pushing aside normal kidney tissue.

The tumor spreads first to nearby lymph nodes, then to distant places like the lungs and liver. Knowing how it spreads helps doctors plan treatment.

Kidney Tissue Involvement

The tumor’s impact on kidney tissue is important. It can press on, invade, or replace normal kidney parts, affecting how well the kidney works. How much the kidney is involved helps doctors understand the disease’s stage and outlook.

Key traits of nephroblastoma include:

  • Cellular heterogeneity: The tumor has a mix of blastemal, epithelial, and stromal elements.
  • Potential for local invasion: Nephroblastoma can spread to nearby kidney tissue and structures.
  • Risk of metastasis: The tumor can spread to distant sites, most commonly the lungs.
  • Variability in presentation: Tumors can be small or large, changing the kidney’s shape.

Epidemiology: Who Gets Wilms Tumor?

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that primarily affects children.

Age Distribution and Incidence

Most kids with Wilms tumor are under 7 years old. The biggest number of cases happen between 3 and 4 years. In the U.S., about 8 kids in a million get it each year.

This cancer mostly hits young children, with the most cases in preschoolers. Knowing this helps doctors and parents watch for signs early on.

Geographical and Demographic Patterns

Where you live can affect if you get Wilms tumor. For example, African-American kids get it more often than white kids. Asian kids get it less.

Genetics might play a part in who gets Wilms tumor. Also, how easy it is to get medical care can affect who gets diagnosed.

Wilms Tumor in Adults

Wilms tumor is mostly a kids’ disease, but it can happen in adults too. When it does, it’s usually more serious and harder to treat.

Doctors need to think about Wilms tumor in adults, even though it’s very rare. This is important for older patients.

Causes and Risk Factors for Developing Nephroblastoma

It’s important to know what causes nephroblastoma to catch it early. Scientists are studying why Wilms tumor happens. They’ve found some genetic, environmental, and family factors that raise the risk.

Genetic Factors and Syndromes

Some genetic syndromes increase the chance of getting Wilms tumor. These include:

  • WAGR syndrome (Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation)
  • Beckwith-Wiedemann syndrome
  • Denys-Drash syndrome
  • Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that primarily affects children.

These syndromes often have gene mutations that affect kidney growth. For example, WT1 gene mutations are linked to some of these syndromes. They raise the risk of Wilms tumor.

Environmental Considerations

There’s not much proof that certain environmental factors cause Wilms tumor. But, some studies look at possible links. These include chemicals and jobs that parents do.

Environmental FactorPotential Risk
Parental exposure to hydrocarbonsIncreased risk
Maternal exposure to certain chemicals during pregnancyPotential increased risk

Familial Patterns

Familial Wilms tumor is rare but shows a genetic link. Families with a history of it should get genetic advice and tests.

In summary, the causes of nephroblastoma are complex. Knowing the genetic, environmental, and family risks helps in early detection. It also helps in finding new treatments.

Signs and Symptoms of Wilms Tumor

It’s important to know the signs of Wilms tumor early. This helps in getting the right treatment fast. We’ll talk about how to spot this condition quickly.

Common Presenting Symptoms

Wilms tumor often shows up as an enlarged belly, pain, and blood in the urine. These signs can be tricky to spot. So, it’s key for parents and doctors to watch closely.

Abdominal swelling is the first sign many notice. Abdominal pain happens when the tumor grows and presses on other tissues.

Rare Manifestations

Some kids might also have high blood pressure or symptoms from the tumor spreading. This can include bone pain or breathing problems.

Symptoms by Age Group

Wilms tumor shows up differently in kids of different ages. Young ones might have a noticeable belly bump. Older kids might feel more general symptoms.

When to Seek Medical Attention

If your child shows any signs of Wilms tumor, get help right away. Catching it early makes a big difference in treatment success.

Diagnostic Process for Nephroblastoma

Understanding how to diagnose nephroblastoma is key to treating it well. This process involves several tests to confirm the disease’s presence and how far it has spread.

Initial Assessment and Physical Examination

The first step is a detailed medical history and physical check-up. We look for signs like belly swelling or pain, which might mean a tumor is present. This initial check helps decide if more tests are needed.

Imaging Studies

Imaging tests are vital for diagnosing nephroblastoma. We often start with ultrasound because it’s safe and gives us important info about the tumor. CT scans

Laboratory Tests

Laboratory tests are also key. Blood tests check overall health and look for signs of tumor effects. Urine tests might be done to see if there’s kidney damage or other tumor-related issues.

Biopsy and Histological Confirmation

A biopsy is needed for a sure diagnosis. It involves taking a tumor sample for microscopic examination. This step is essential for confirming cancer cells and understanding the tumor’s type, which helps plan treatment.

By combining findings from the initial check, imaging, lab tests, and biopsy, we can accurately diagnose nephroblastoma. This allows us to create a good treatment plan.

Nephroblastoma vs. Neuroblastoma: Key Differences

Nephroblastoma and neuroblastoma are two types of cancer in kids. They come from different places in the body and need different treatments. Knowing the differences helps doctors give the right care.

Origin and Cell Types

Nephroblastoma, or Wilms tumor, starts in the kidney. It comes from cells called metanephric blastema. Neuroblastoma, on the other hand, starts in nerve cells. These cells are part of the nervous system.

Clinical Presentation Differences

Nephroblastoma often shows up as a big mass in the belly. It might be found by accident or during a check-up. Sometimes, kids with nephroblastoma have fever, high blood pressure, or blood in their pee.

Neuroblastoma can cause many symptoms. It might show up as a belly mass, bulging eyes, or problems with moving because of a tumor on the spine.

Diagnostic Distinctions

Doctors use special tests to tell nephroblastoma and neuroblastoma apart. Nephroblastoma looks like a solid mass in the kidney on scans. Neuroblastoma shows up in the nerve system and might have calcium spots.

The only way to really know what kind of cancer it is is with a biopsy. This test looks at the cells under a microscope.

Treatment Approach Variations

Treatment for nephroblastoma usually includes surgery, chemo, and sometimes radiation. It depends on how big the tumor is and what it looks like. Neuroblastoma treatment depends on how likely it is to spread. It might include chemo, surgery, radiation, or special treatments like immunotherapy.

In short, nephroblastoma and neuroblastoma are two different cancers in kids. They come from different places, look different, and need different treatments. Accurate diagnosis and the right treatment are key to helping kids get better.

Comprehensive Staging System for Wilms Tumor

Understanding Wilms tumor staging is key to knowing how far the disease has spread. It helps doctors decide the best treatment. The system looks at the tumor’s size, where it is, and if it has spread.

Early Disease: Stage 1 and 2

Stage 1 Wilms tumor is small and only in the kidney. It’s removed during surgery without any issues. Stage 2 tumors are bigger but also removed. They might touch nearby tissues but not spread further.

Both stages have a good chance of recovery with the right treatment.

Advanced Local Disease: Stage 3

Stage 3 tumors spread beyond the kidney and lymph nodes. They’re harder to remove. There might be leftover tumor in the abdomen.

This stage needs strong treatments like surgery, chemo, and radiation.

Metastatic Disease: Stage 4

Stage 4 tumors have spread to distant places like the lungs or liver. Treatment is tough and often includes chemo and radiation.

Survival chances are lower, but new treatments are helping more people live longer.

Bilateral Involvement: Stage 5

Stage 5 tumors are in both kidneys. Treating them is very challenging. Doctors must balance fighting the tumor and keeping kidney function.

Managing Stage 5 tumors needs a team effort. This includes surgery, chemo, and sometimes radiation. The goal is to keep as much kidney function as possible.

StageDescriptionTreatment Approach
Stage 1Tumor limited to the kidney, completely excisedSurgery, possibly chemotherapy
Stage 2Tumor extends beyond the kidney, completely removedSurgery, chemotherapy
Stage 3Residual tumor after surgery, confined to the abdomenSurgery, chemotherapy, radiation therapy
Stage 4Metastatic disease to distant parts of the bodyAggressive chemotherapy, possibly radiation therapy
Stage 5Bilateral kidney involvementMultidisciplinary approach, including surgery, chemotherapy, and radiation therapy

A study on Wilms tumor says, “The accurate staging of Wilms tumor is critical for determining the prognosis and guiding the treatment plan.” (

This shows how important a detailed staging system is for treating Wilms tumor well.

)

Histological Classification of Nephroblastoma

The way we classify nephroblastoma histologically is key to knowing how well a patient will do. It helps us understand the tumor’s nature. This is vital for planning the best treatment.

Favorable Histology

Nephroblastomas with favorable histology have cells that look like normal kidney cells. These tumors usually have a better outlook than those with unfavorable histology.

Anaplastic Histology

Anaplastic histology shows cells with odd nuclei, meaning the tumor is aggressive. This type of tumor is harder to treat and has a worse prognosis.

Blastemal Predominant Type

The blastemal predominant type has lots of immature cells. These cells haven’t turned into mature kidney cells yet. This type is tough to treat because it’s very aggressive.

Prognostic Implications of Histology

The type of histology in nephroblastoma greatly affects the patient’s outlook. Tumors with favorable histology tend to do better. But, tumors with anaplastic or blastemal predominant features need more intense treatment and have a worse outlook.

We summarize the key features and prognostic implications of different histological types in the following table:

Histological TypeCharacteristicsPrognosis
Favorable HistologyWell-differentiated cells resembling normal kidney tissueBetter prognosis
Anaplastic HistologyCells with abnormal nuclei, indicating aggressive tumor typePoorer prognosis
Blastemal Predominant TypePredominance of immature blastemal cellsChallenging to treat, poorer prognosis

Treatment Approaches for Wilms Tumor

The treatment of Wilms tumor has changed a lot. Now, doctors use a mix of different medical fields. This approach aims to get the best results for patients.

Surgical Management

Surgery is key in treating Wilms tumor. The main goal is to take out the tumor and check how far it has spread.

  • Nephrectomy: This is when the affected kidney is removed.
  • Lymph Node Sampling: Doctors take samples of nearby lymph nodes to see if the tumor has spread.
  • Tumor Resection: Sometimes, doctors need to remove the tumor from the surrounding tissues.

Chemotherapy Protocols

Chemotherapy is very important in treating Wilms tumor. It’s used before and after surgery. The treatment plans depend on the tumor’s stage and type.

  1. Pre-operative Chemotherapy: This helps shrink the tumor, making it easier to remove.
  2. Post-operative Chemotherapy: It’s given to kill any cancer cells left behind.

Radiation Therapy Indications

In some cases, radiation therapy is used. This is when the disease is advanced or has spread to other areas.

  • External Beam Radiation Therapy (EBRT): This is the most common type, where radiation comes from outside the body.
  • Indications: It’s used for cases with leftover disease after surgery or when the tumor has spread.

Novel and Targeted Therapies

Doctors are always looking for new and targeted treatments. These could be more effective and have fewer side effects.

These new therapies might help improve treatment results for Wilms tumor patients.

Management Strategies for Advanced Disease

Advanced Wilms tumor needs aggressive and tailored management. It requires a mix of treatments and supportive care. This approach helps manage the disease’s complexity.

Treating Stage 3 Wilms Tumor

Stage 3 Wilms tumor has tumor cells beyond the kidney but within the regional area. Treatment includes surgery, chemotherapy, and radiation therapy. The goal is to remove the tumor and stop it from spreading.

Key treatment components for stage 3 Wilms tumor include:

  • Surgical removal of the tumor and affected kidney (nephrectomy)
  • Chemotherapy to target remaining cancer cells
  • Radiation therapy to treat any residual disease in the abdomen

Approaches for Stage 4 Disease

Stage 4 Wilms tumor has spread to distant parts of the body, like the lungs, liver, or bones. Managing stage 4 disease needs an intense treatment plan. This may include:

  • Aggressive chemotherapy regimens
  • Radiation therapy to control symptoms and reduce tumor burden
  • Surgery to remove the primary tumor and, in some cases, metastatic sites

Managing Recurrent Disease

Recurrent Wilms tumor is challenging and needs a new treatment plan. Management strategies for recurrent disease may include:

  • Second-line chemotherapy
  • Targeted therapy or novel agents in clinical trials
  • Palliative care to improve quality of life

Supportive Care Considerations

Supportive care is key in managing advanced Wilms tumor. It focuses on easing symptoms, managing side effects, and improving quality of life. Supportive care may include:

  • Pain management
  • Nutritional support
  • Psychological counseling for patients and families

Managing advanced Wilms tumor needs a team approach. It includes the latest treatments and supportive care. The table below summarizes key aspects of managing advanced disease:

Disease StageTreatment ModalitiesSupportive Care
Stage 3Surgery, Chemotherapy, RadiationPain management, Nutritional support
Stage 4Aggressive Chemotherapy, Radiation, SurgerySymptom control, Psychological counseling
RecurrentSecond-line Chemotherapy, Targeted therapyPalliative care, Quality of life improvement

Prognosis and Survival Rates

The outlook for Wilms tumor changes a lot based on several things. These include the stage and type of tumor. Knowing these details helps patients and their families understand what to expect.

Factors Affecting Prognosis

Many things can change how likely a patient is to survive Wilms tumor. These include the disease’s stage, the tumor’s type, the patient’s age, and how well they respond to treatment.

  • Stage of Disease: The stage at diagnosis greatly affects the outlook. Early stages (I and II) have a better chance of recovery than later stages (III, IV, and V).
  • Histology: The tumor’s type, whether it’s favorable or anaplastic, is very important for the prognosis.
  • Age and Overall Health: The patient’s age and health at diagnosis also play a role in the prognosis.

Stage-Specific Survival Rates

Thanks to better treatments, survival rates for Wilms tumor have gone up. The rates vary by stage:

StageSurvival Rate
Stage I95-100%
Stage II90-95%
Stage III80-90%
Stage IV70-80%
Stage V50-70%

Long-term Survival and Quality of Life

Survival rates for Wilms tumor have improved over time. But, it’s also important to think about the quality of life. Survivors might face problems like kidney issues, hearing loss, and a higher risk of getting other cancers.

Life Expectancy for Stage 4 Patients

For Stage 4 Wilms tumor patients, the outlook is generally less good. But, with aggressive treatment like chemotherapy and radiation, many can live a long time.

We know that every patient’s story is different. The prognosis can change based on many personal factors. Our team is dedicated to giving full care and support. We aim to improve outcomes and quality of life for Wilms tumor patients.

Conclusion

Great strides have been made in treating Wilms tumor, also known as nephroblastoma. These advances have led to better survival rates for those diagnosed. Research has deepened our knowledge of nephroblastoma’s causes, symptoms, and how to diagnose it. Now, doctors can tailor treatments based on each patient’s needs. This is thanks to detailed staging systems and histological classification. Thanks to ongoing research, treatments now include surgery, chemotherapy, and radiation therapy. These new approaches have greatly improved patient outcomes for Wilms tumor. It’s vital to keep funding research into nephroblastoma. This will help us find even better treatments and improve survival rates and quality of life for those affected.

FAQ

What is Wilms tumor, and what is its alternative name?

Wilms tumor, also known as nephroblastoma, is a type of kidney cancer. It mainly affects children. It is named after Max Wilms, who helped discover it.

Why is Wilms tumor known by two different names?

It’s called Wilms tumor and nephroblastoma for different reasons. “Wilms tumor” honors Max Wilms, who first described it. “Nephroblastoma” comes from the Greek words for kidney and tumor.

What are the common signs and symptoms of Wilms tumor?

Signs include a big belly mass, pain, fever, and blood in the urine. Some kids might also lose weight or feel very hungry.

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that primarily affects children.

Doctors use ultrasound, CT scans, or MRI to find the tumor. They also do lab tests and biopsies to confirm it’s cancer.

What is the difference between nephroblastoma and neuroblastoma?

Nephroblastoma comes from kidney cells, while neuroblastoma comes from nerve cells. Their symptoms, diagnosis, and treatment are different.

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer that primarily affects children.

It’s staged from I to V based on the tumor’s size and spread. This helps decide the treatment and how well the patient will do.

What are the treatment approaches for Wilms tumor?

Treatment includes surgery, chemotherapy, and sometimes radiation. New treatments are being tested too.

What is the prognosis for Wilms tumor patients?

The outlook depends on the stage, type, and how well the tumor responds to treatment. Early diagnosis helps a lot.

How does the histological classification affect the prognosis?

The type of tumor cells affects the outcome. Tumors with favorable cells have a better chance of recovery. Anaplastic tumors are harder to treat.

What are the management strategies for advanced Wilms tumor?

Advanced cases need strong treatments like chemotherapy and radiation. Surgery might also be needed. Supportive care helps with symptoms and side effects.

What is the life expectancy for stage IV Wilms tumor patients?

Life expectancy for stage IV patients depends on treatment response and tumor type. Despite being serious, new treatments have improved survival chances.

Are there any genetic factors associated with Wilms tumor?

Yes, some genetic factors increase the risk of Wilms tumor. Genetic testing and counseling are advised for those at high risk.

Can Wilms tumor occur in adults?

While rare, Wilms tumor can happen in adults. Treatment for adults might be different from that for children.

References

  • Green, D. M., et al. (2009). Early and late mortality after diagnosis of Wilms tumor. Journal of Clinical Oncology, 27(1), 112-119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667828/
  • National Cancer Institute. (2025). Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Patient Version. https://www.cancer.gov/types/kidney/hp/wilms-treatment-pdq
  • Gailani, M., et al. (2022). Multidisciplinary treatment strategies for Wilms tumor: Recent advances, technical innovations and future directions. Frontiers in Pediatrics, 10, 852185. https://www.frontiersin.org/articles/10.3389/fped.2022.852185/full
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics

Assoc. Prof. MD. Muhammet Ali Varkal

Liv Hospital Ulus
Spec. MD. Gizem Güvener Pediatrics

Spec. MD. Gizem Güvener

Liv Hospital Ulus
Spec. MD. Osman Karlı Pediatrics

Spec. MD. Osman Karlı

Liv Hospital Ulus
Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU)

Spec. MD. Tamer Ünver

Liv Hospital Ulus
Assoc. Prof. MD. Adem Dursun Pediatrics

Assoc. Prof. MD. Adem Dursun

Liv Hospital Vadistanbul
Psyc. Selenay Yücel Keleş Pediatric Psychology

Psyc. Selenay Yücel Keleş

Liv Hospital Vadistanbul
Spec. MD.  Fatih Aydın Pediatrics

Spec. MD. Fatih Aydın

Liv Hospital Vadistanbul
Spec. MD. Dicle Çelik Pediatrics

Spec. MD. Dicle Çelik

Liv Hospital Vadistanbul
Spec. MD. Elif Erdem Özcan Pediatrics

Spec. MD. Elif Erdem Özcan

Liv Hospital Vadistanbul
Spec. MD. Hilal Kızıldağ Pediatrics

Spec. MD. Hilal Kızıldağ

Liv Hospital Vadistanbul
Spec. MD. Mehmet Kılıç Pediatrics

Spec. MD. Mehmet Kılıç

Liv Hospital Vadistanbul
Spec. MD. Ozan Uzunhan Neonatology

Spec. MD. Ozan Uzunhan

Liv Hospital Vadistanbul
Spec. MD. Selami Bayrakdar Pediatrics

Spec. MD. Selami Bayrakdar

Liv Hospital Vadistanbul
Spec. MD. Semra Akkuş Akman Pediatrics

Spec. MD. Semra Akkuş Akman

Liv Hospital Vadistanbul
Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases

Asst. Prof. MD. Doruk Gül

Liv Hospital Bahçeşehir
Prof. MD. Murat Sütçü Pediatric Health and Diseases

Prof. MD. Murat Sütçü

Liv Hospital Bahçeşehir
Prof. MD. Nihat Demir Pediatrics

Prof. MD. Nihat Demir

Liv Hospital Bahçeşehir
Psyc. (Psychologist) Buse Yağmur Pediatric Psychology

Psyc. (Psychologist) Buse Yağmur

Liv Hospital Bahçeşehir
Spec. MD. Cansu Muluk Pediatrics

Spec. MD. Cansu Muluk

Liv Hospital Bahçeşehir
Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases

Spec. MD. Dilek Hatipoğlu

Liv Hospital Bahçeşehir
Spec. MD. Duygu Amine Garavi Pediatrics

Spec. MD. Duygu Amine Garavi

Liv Hospital Bahçeşehir
Spec. MD. Fatih Kaya Pediatric Health and Diseases

Spec. MD. Fatih Kaya

Liv Hospital Bahçeşehir
Spec. MD. Günel Nüsretzade Elmar Pediatrics

Spec. MD. Günel Nüsretzade Elmar

Liv Hospital Bahçeşehir
Spec. MD. Melike Akar Pediatrics

Spec. MD. Melike Akar

Liv Hospital Bahçeşehir
Liv Hospital Topkapı
Spec. MD. Mey Talip Pediatric Intensive Care

Spec. MD. Mey Talip

Liv Hospital Bahçeşehir
Spec. MD. Negın Nahanmoghaddam Pediatrics

Spec. MD. Negın Nahanmoghaddam

Liv Hospital Bahçeşehir
Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases

Spec. MD. Nushaba Abdullayeva

Liv Hospital Bahçeşehir
Spec. MD. Refika İlbakan Hanımeli Pediatrics

Spec. MD. Refika İlbakan Hanımeli

Liv Hospital Bahçeşehir
Spec. MD. Selman Alazab Pediatrics

Spec. MD. Selman Alazab

Liv Hospital Bahçeşehir
Spec. MD. Özden Durmuş Gönültaş Pediatrics

Spec. MD. Özden Durmuş Gönültaş

Liv Hospital Bahçeşehir
Spec. Md. Öznur Ceylan Pediatric Health and Diseases

Spec. Md. Öznur Ceylan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Aslan Yılmaz Neonatology

Assoc. Prof. MD. Aslan Yılmaz

Liv Hospital Topkapı
Prof. MD. Alpay Çakmak Pediatrics

Prof. MD. Alpay Çakmak

Liv Hospital Topkapı
Spec. MD. Demet Deniz Bilgin Pediatrics

Spec. MD. Demet Deniz Bilgin

Liv Hospital Topkapı
Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry

Spec. MD. Nesrin Köseoğlu

Liv Hospital Topkapı
Spec. MD. Seçil Sözen Pediatrics

Spec. MD. Seçil Sözen

Liv Hospital Topkapı
Spec. MD. Özge Akça Pediatrics

Spec. MD. Özge Akça

Liv Hospital Topkapı
Spec. MD. Şeyma Öz Pediatrics

Spec. MD. Şeyma Öz

Liv Hospital Topkapı
Asst. Prof. MD. Pakize Elif Alkış Pediatrics

Asst. Prof. MD. Pakize Elif Alkış

Liv Hospital Ankara
Prof. MD. Musa Kazım Çağlar Pediatrics

Prof. MD. Musa Kazım Çağlar

Liv Hospital Ankara
Prof. MD. İbrahim Hakan Bucak Pediatrics

Prof. MD. İbrahim Hakan Bucak

Liv Hospital Ankara
Prof.MD. Sevgi Başkan Pediatrics

Prof.MD. Sevgi Başkan

Liv Hospital Ankara
Spec. MD. Büşra Süzen Celbek Pediatrics

Spec. MD. Büşra Süzen Celbek

Liv Hospital Ankara
Spec. MD. Galip Erdem Pediatrics

Spec. MD. Galip Erdem

Liv Hospital Ankara
Spec. MD. Hafsa Uçur Pediatric Health and Diseases

Spec. MD. Hafsa Uçur

Liv Hospital Ankara
Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases

Spec. MD. Hidayet Katipoğlu

Liv Hospital Ankara
Spec. MD. Hüsniye Altan Pediatrics

Spec. MD. Hüsniye Altan

Liv Hospital Ankara
Spec. MD. Mehmet Turfanda Pediatric Health and Diseases

Spec. MD. Mehmet Turfanda

Liv Hospital Ankara
Spec. MD. Mustafa Yücel Kızıltan Pediatrics

Spec. MD. Mustafa Yücel Kızıltan

Liv Hospital Ankara
Spec. MD.  Seral Navdar Pediatric Health and Diseases

Spec. MD. Seral Navdar

Liv Hospital Gaziantep
Spec. MD. Gül Balyemez Pediatric Health and Diseases

Spec. MD. Gül Balyemez

Liv Hospital Gaziantep
Spec. MD. Hasan Avşar Neonatology

Spec. MD. Hasan Avşar

Liv Hospital Gaziantep
Spec. MD. Mert Çakır Pediatrics

Spec. MD. Mert Çakır

Liv Hospital Gaziantep
Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases

Spec. MD. Saltuk Buğra Böke

Liv Hospital Gaziantep
Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases

Spec. MD. Özlem Karaoğlu

Liv Hospital Gaziantep
Spec. MD. İsmail Ersan Can Pediatric Health and Diseases

Spec. MD. İsmail Ersan Can

Liv Hospital Gaziantep
Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases

Spec. MD. Şekibe Zehra Doğan

Liv Hospital Gaziantep
Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases

Spec. MD. Gülsenem Sarı Aracı

Liv Hospital Samsun
Spec. MD. Nazlı Karakullukcu Çebi Pediatrics

Spec. MD. Nazlı Karakullukcu Çebi

Liv Hospital Samsun
Spec. MD. Nezih Akgün Pediatric Health and Diseases

Spec. MD. Nezih Akgün

Liv Hospital Samsun
Spec. MD. Pelin Aytaç Uras Pediatrics

Spec. MD. Pelin Aytaç Uras

Liv Hospital Samsun
MD. VEFA İSAYEVA Pediatric Health and Diseases

MD. VEFA İSAYEVA

Liv Bona Dea Hospital Bakü
Spec. MD.  Elnur Hüseynov Pediatrics

Spec. MD. Elnur Hüseynov

Liv Bona Dea Hospital Bakü
Spec. MD. INARE ELDAROVA Pediatrics

Spec. MD. INARE ELDAROVA

Liv Bona Dea Hospital Bakü
Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases

Spec. MD. SADİQ İSMAYILOV

Liv Bona Dea Hospital Bakü
MD. Dr. Elnur Hüseynov Pediatrics

MD. Dr. Elnur Hüseynov

Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry

Spec. MD. Doğa Sevinçok

Pediatrics

Spec. MD. Sadık İsmayılov

Related Videos

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91